Kharchafi A, Morlat P, Bernard P-H, Bernard N, Balabaud C, Beylot J
Service de médecine interne et maladies infectieuses, groupe hospitalier Saint-André, CHU de Bordeaux, France.
Rev Med Interne. 2006 Dec;27(12):916-23. doi: 10.1016/j.revmed.2006.03.002. Epub 2006 Apr 3.
The hepatitis C-Autoimmune hepatitis overlap syndrome is an uncommon condition whose management can be difficult in both diagnosis and treatment.
Five cases of hepatitis C and autoimmune hepatitis overlap syndrome, brought by a retrospective study, are reported. Hepatitis C was proven by a positive HCV viral load and the autoimmune hepatitis was proven by characteristic immunological and/or histological features.
All patients were female, the mean age at diagnosis was 54.2 years (+/-6.6), only one patient had a history of autoimmune disease (autoimmune thyroiditis). Four patients had significant autoantibodies levels (over 1/320) and 4 had a high serum gammaglobulin level (over 1.5 times the upper normal limit). Liver biopsy showed characteristic features of autoimmune hepatitis in all cases and characteristic features of chronic HCV infection in 3 cases. Corticosteroid and/or immunosuppressive treatment was given as a first line therapy in 4 cases while an antiviral treatment has been tried in 4 cases with a good viral response in 2 of them. Corticosteroid and/or immunosuppressive treatment enhanced HCV viral load in all cases, however a histological improvement was observed in every case in which a control biopsy has been performed (3 cases).
This study highlights the deciding contribution of the initial histological findings in the diagnosis of such a HCV/autoimmune hepatitis overlap syndrome; it also demonstrates that histological outcome is not necessarily compromised by corticosteroid and/or immunosuppressive treatment.
丙型肝炎-自身免疫性肝炎重叠综合征是一种罕见疾病,其诊断和治疗都可能存在困难。
报告了5例通过回顾性研究得出的丙型肝炎和自身免疫性肝炎重叠综合征病例。丙型肝炎通过HCV病毒载量阳性得到证实,自身免疫性肝炎通过特征性的免疫学和/或组织学特征得到证实。
所有患者均为女性,诊断时的平均年龄为54.2岁(±6.6),只有1例患者有自身免疫性疾病史(自身免疫性甲状腺炎)。4例患者自身抗体水平显著升高(超过1/320),4例患者血清γ球蛋白水平升高(超过正常上限的1.5倍)。肝活检在所有病例中均显示出自身免疫性肝炎的特征性表现,3例显示出慢性HCV感染的特征性表现。4例患者接受了皮质类固醇和/或免疫抑制治疗作为一线治疗,4例患者尝试了抗病毒治疗,其中2例病毒反应良好。皮质类固醇和/或免疫抑制治疗在所有病例中均使HCV病毒载量升高,然而,在进行对照活检的每例病例(3例)中均观察到组织学改善。
本研究强调了初始组织学检查结果在诊断此类HCV/自身免疫性肝炎重叠综合征中的决定性作用;同时也表明,皮质类固醇和/或免疫抑制治疗不一定会损害组织学结果。